Exact Soars As Guardant’s Blood Test Trails Cologuard In Colon Cancer
Guardant Health (GH) unveiled pivotal results for its colon cancer-detecting blood test that lagged rival Exact Sciences (EXAS) — leading GH stock to crash Friday. Meanwhile, EXAS stock skyrocketed.
X
In the final-phase study,…